Xiaoping Ji
Overview
Explore the profile of Xiaoping Ji including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mou K, Ji X, Li X, Zhou H, Wu Y, Fang Y
Materials (Basel)
. 2025 Feb;
18(4).
PMID: 40004310
Smart pavement is composed of a monitor network, communication network, data center, and energy supply system, and it requires reliable and efficient energy sources to power sensors and devices. The...
2.
Chen N, Xiao J, Luo Y, Fu K, Sun Z, Zhang X, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1447791.
PMID: 39629048
Background: Peripartum cardiomyopathy (PPCM) is a form of heart failure that severely affects women during the late stages of pregnancy and in the postpartum period. Currently, the diagnosis of PPCM...
3.
Ji X, Yu H, Wang L, Bao X, Si T, Li X, et al.
Front Pharmacol
. 2024 Nov;
15:1418063.
PMID: 39559734
(LR) is a folk medicinal herb traditionally used as a lipid-lowering and anti-obesity agent; but its pharmacological mechanism is unclear. In this study, we assessed the alterations of LR on...
4.
Fu K, Dong Y, Wang Z, Teng J, Cheng C, Su C, et al.
Cardiovasc Diabetol
. 2024 Sep;
23(1):334.
PMID: 39261931
Background: Although the "obesity paradox" is comprehensively elucidated in heart failure (HF) with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the role of body composition in...
5.
Lin Z, Zhang X, Liu Y, Miao D, Zhang H, Zhang T, et al.
ESC Heart Fail
. 2024 Sep;
11(6):4381-4389.
PMID: 39225306
Aims: Left ventricular hypertrophy (LVH) is frequently detected via echocardiography in individuals with Fabry disease (FD), sometimes leading to confusion with hypertrophic cardiomyopathy (HCM) of other aetiologies. Considering this diagnosis...
6.
Fu K, Cheng C, Su C, Teng J, Qiao L, Xiao J, et al.
Cardiovasc Diabetol
. 2024 Apr;
23(1):131.
PMID: 38637777
Background: Serum uric acid (SUA) is an important pathogenetic and prognostic factor for heart failure (HF). Gender differences are apparent in HF. Furthermore, gender differences also exist in the association...
7.
Ji X, Ma Q, Wang X, Ming H, Bao G, Fu M, et al.
J Ethnopharmacol
. 2023 Jun;
317:116827.
PMID: 37348794
Ethnopharmacological Relevance: Nonalcoholic fatty liver disease (NAFLD) is a manifestation of metabolic syndrome in the liver and the leading cause of chronic liver disease worldwide. Digeda-4 decoction (DGD-4) is a...
8.
Wang C, Lin Z, Miao D, Zhang H, Fu K, Zhang X, et al.
ESC Heart Fail
. 2023 Mar;
10(3):1961-1971.
PMID: 36991256
Aims: The study aims to explore the real-world titration patterns of sacubitril/valsartan in a chronic heart failure (HF) follow-up management system and the effect on the recovery of ventricular remodelling...
9.
Zhang X, Sun Y, Li Y, Wang C, Wang Y, Dong M, et al.
Clin Cardiol
. 2023 Jan;
46(3):310-319.
PMID: 36651220
Background: Obesity is an important risk factor for heart failure (HF). Hypothesis: Visceral adiposity index (VAI) is a simple metric for assessing obesity; however, the association between VAI and risk...
10.
Cheng J, Xue F, Cheng C, Sui W, Zhang M, Qiao L, et al.
Front Pharmacol
. 2022 Oct;
13:997916.
PMID: 36313337
A disintegrin and metalloprotease domain family protein 17 (ADAM17) is a new member of renin-angiotensin system (RAS) but its role in the pathogenesis of diabetic cardiomyopathy (DCM) is obscure. To...